Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia

• Status: Terminated
• Trial end date: 2016-09-30
• Target enrollment: 0
• Participant gender: Female

Summary

With this research the investigators hope to determine the lowest dose of ropivacaine used in transversus abdominis plane (TAP) blocks that can effectively treat pain in women after cesarean section (c-section).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Maimonides Medical Center
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Pregnant patients undergoing elective c-section

Exclusion criteria:

• Allergy to local anesthetics

• Contraindication to tap blocks